Shuning Ding
Shanghai Jiao Tong University
19 Papers
43 Citations
Shuning Ding is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 6, co-authored 14 publications.
Chat about Author
Papers
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
TL;DR: A brief introduction on the currently available scRNA‐seq approaches along with their corresponding strengths and weaknesses is provided and may act as a reference for the selection of suitable methods for research.
189
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study.
TL;DR: This study has provided population-based prognostic analysis in patients with initial bone metastatic breast cancer and constructed a predicting nomogram with good accuracy, finding of potential benefit of surgery to overall survival will cast some lights on the treatment tactics of this group of patients.
Single‐cell atlas reveals a distinct immune profile fostered by T cell‐B cell crosstalk in triple negative breast cancer
Shuning Ding,Niu Qiao,Qingchen Zhu,Yiwei Tong,Shengyue Wang,Xiaohong Chen,Qiang Tian,Yichuan Xiao,Kunwei Shen +8 more
TL;DR: In this paper, the unique features of the immune microenvironment of triple negative breast cancer (TNBC) compared with other subtypes of breast cancer remain elusive, and the authors aimed to depict and compare the immune landscape among TNBC, human epidermal growth factor receptor 2−positive (HER2+) breast cancer, and luminal-like breast cancer.
21
Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
Caijin Lin,Jiayi Wu,Shuning Ding,Chihwan Goh,Lisa Andriani,Shuangshuang Lu,Kunwei Shen,Li Zhu +7 more
TL;DR: Subdivision of M1 stage facilitates prognosis prediction and treatment planning for patients with de novo metastatic breast cancer and may play an important role in the management of selected patients.
Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score–Adjusted, Population-Based Study
TL;DR: Prior cancer provides an inferior OS but a superior BCSS for patients with ABC and it does not affect the survival adversely in some subgroups and these patients should not be excluded from clinical trials.